MOLPoints是东南亚主流的在线支付方式之一,也是一种游戏点卡,在线下便利店、网吧等网点可以轻松购买到,MOLPoints可购买在线游戏内容,包括Facebook游戏卡。其他业务包括MOLPay,在线内容支付解决方案;http://MMOG.asia,在线游戏门户;MOLWallet,在线手机支付系统;MOLReloads,数字内容及话费预付卡业务等。 覆盖国家:马来西亚、...
MOLPoints MOLPoints- 预付卡(东南亚点卡) MOL是东南亚最大的在线商品和服务电子支付商。截至至今年3月31日,实体渠道涵盖4大洲,13个国家的92万家实体销售点。同时该公司也拥有移动和电子渠道,接受全球94家银行的在线支付和信用卡业务。 MOL主要产品为MOL点卡,MOLPoints可购买在线游戏内容,包括Facebook游戏卡。其他业务...
说明:玩家可以购买MOLPoints点卡充值MOL钱包里面,也可以购买MOLPoints点卡直接付款。 覆盖国家: 马来西亚、泰国、菲律宾、印度尼西亚、越南、新加坡、澳大利亚、新西兰、巴西、印度等国家。 马来西亚MOLPoints面值及点数: Default Description API Amount MOLPointsCard RM3 =300 MOLPointsCard RM5 =500 MOLPointsCard RM7 ...
海外如何购买全服通用MOL Points卡密 ? MOLPoints点卡是东南亚非常大的在线支付MOL发行的游戏点卡。MOL是东南亚非常大的在线商品和服务电子支付商,在土耳其以及巴西等地覆盖了数万处实体点,实体渠道涵盖4大洲,13个国家。 客户可以通过MOLPoints的12个本地化门户来购
mol points 青云英语翻译 请在下面的文本框内输入文字,然后点击开始翻译按钮进行翻译,如果您看不到结果,请重新翻译! 翻译结果1翻译结果2翻译结果3翻译结果4翻译结果5 翻译结果1复制译文编辑译文朗读译文返回顶部 摩尔点 翻译结果2复制译文编辑译文朗读译文返回顶部...
Z-Mol Points Digital Gift Voucher Group PurchaseQuestions? Brand Description http://www.mol.com zGold-MOLPoints is a virtual currency which you can use to purchase over 10,000+ Games, Digital Content and Services. From Game Credits to Digital Content, MOL’s goal is to provide you with th...
zGOLD-MOLPOINTS IS NOW RAZER GOLD Get more back on every dollar you spend and enjoy exclusive gaming deals with us. Be rewarded with Razer Silver, the loyalty rewards program just for you. Upgrade your MOL account to continue enjoying our services with the new Razer Gold. UPGRADE NOW ...
mol.com 1 MOL - Money Online | Purchase MOLPoints with Skrill http://www.mol.com/paymentchannel/faq/50 British Indian Ocean Territory. Cote DIvoire (Ivory Coast). Finland, Aland Islands. Heard and McDonald Islands. Macedonia, Former Yugoslav Republic of. Micronesia, Federated States of. S ...
In previous work, Costa and Alves (J Math Sci 161:(6)820鈥 831, 2009 ; 2011 ) have presented Branch & Bound and Branch & Cut techniques that allow for the effective computation of nondominated solutions, associated with reference points, of multi-objective linear fractional programming (MOL...
The latest data from Merck and Ridgeback Biotherapeutics' MOVe-OUT trial on the use of molnupiravir to treat COVID-19 in adults has shown a lower efficacy than previously reported.